Can serum interleukin-17 and interleukin-10 levels predict response to biologic treatments in patients with rheumatoid arthritis?

Rheumatology (Oxford). 2019 Oct 1;58(10):1872-1873. doi: 10.1093/rheumatology/kez147.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / blood*
  • Arthritis, Rheumatoid / drug therapy
  • Biological Products / therapeutic use*
  • Female
  • Humans
  • Interleukin-10 / blood*
  • Interleukin-17 / blood*
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Biological Products
  • IL10 protein, human
  • IL17A protein, human
  • Interleukin-17
  • Interleukin-10